Is Peptide Therapy Legal in Nevada? Choosing a Legitimate Clinic
By Charles Kamen, MD, board-certified neurologist
Peptide therapy is legal in Las Vegas: a peptide used in patient care is a prescription drug, and it is legal to receive when a Nevada-licensed practitioner prescribes it after a bona fide medical evaluation and a licensed pharmacy dispenses it. [1] The first question to settle is not price — it is that prescribing relationship, which is what separates real, physician-led care from a peptide storefront.
This guide leads with Nevada law and FDA compounding status, then walks through the red and green flags that separate legitimate care from "research use only" sales. For a focused breakdown of the law, see is peptide therapy legal in Nevada; when you are ready to look at what care costs, see our pricing page.
Is Peptide Therapy Legal in Las Vegas, Nevada?
Yes — with conditions. In Nevada a peptide is legal to receive when two things are true at once: it is prescribed by a Nevada-licensed practitioner after a bona fide medical evaluation, and it is dispensed by a licensed pharmacy. [1]
Legality is not about a molecule being "banned" or "approved" in the abstract — it turns on the prescribing relationship and the pharmacy. Buying the same peptide from a "research use only" website with no prescription is not legal medical use, and those products are not manufactured or tested for human administration.
Nevada also permits peptide prescribing via telemedicine once a valid provider-patient relationship is established, under the state's telehealth statute. [2] That is why a legitimate, physician-led Las Vegas clinic can continue to see Nevada residents remotely after an initial evaluation.
FDA Status of Common Peptides in 2026
"FDA-approved" and "legally prescribable" are not the same thing. Some peptides are approved drugs; others are legal only because a licensed pharmacy may compound them under specific FDA rules. The complete physician-maintained list lives in our which peptides are FDA-approved guide. Here is where the commonly requested peptides stand as of 2026:
- Semaglutide (Wegovy, Ozempic) — FDA-approved. Wegovy was approved for chronic weight management in 2021. [3]
- Tirzepatide (Zepbound, Mounjaro) — FDA-approved. Zepbound was approved for chronic weight management in November 2023. [4]
- Bremelanotide (Vyleesi, a melanocortin peptide) — FDA-approved in 2019 for hypoactive sexual desire disorder in premenopausal women.
- BPC-157 — not FDA-approved. In 2023 the FDA placed BPC-157 in the category of substances it identified as raising significant compounding safety questions, which restricts how 503A pharmacies may compound it. [5]
- Sermorelin (a growth-hormone-releasing peptide) — not currently an approved finished drug (the original branded product was discontinued); availability depends on compounding status at a given time.
- CJC-1295 / ipamorelin / tesamorelin-class secretagogues — mixed: tesamorelin (Egrifta) is FDA-approved for a specific HIV-associated indication; CJC-1295 and ipamorelin are not approved finished drugs and depend on compounding rules.
- NAD+ — not a drug approval question in the usual sense; it is compounded for IV/injectable use and provided under a prescription after evaluation.
Why the FDA Compounding Rules Decide What You Can Actually Get
Most peptides patients ask about are not mass-produced approved drugs — they are compounded by licensed pharmacies. The FDA regulates this through two pathways: 503A pharmacies, which compound for an individual patient's prescription, and 503B outsourcing facilities, which manufacture larger batches under stricter cGMP oversight. [5]
When the FDA flags a substance as raising safety questions for compounding — as it did with several peptides in 2023 — pharmacies may restrict or stop compounding it. That is why the list of available peptides changes over time, and why a clinic that promises a specific peptide indefinitely is making a claim it cannot support. A physician-led clinic prescribes only what is lawfully compoundable at that moment.
What Peptide Therapy Costs in Las Vegas (2026)
Cost depends on the peptide, the dose, the pharmacy, and how long you stay on a protocol — so any single "price" is misleading. The figures below are typical 2026 market ranges for the Las Vegas area, not quotes, and are provided to set realistic expectations. Your actual cost is determined after evaluation.
- Initial medical evaluation: $88 at LiveNow Longevity. Many clinics charge $150–$400 for a first visit; some "free consult" models recover the cost in the protocol price.
- Comprehensive lab panel (when ordered): roughly $150–$600 depending on markers and whether insurance covers any of it.
- Growth-hormone-secretagogue peptides (e.g., sermorelin, ipamorelin combinations): commonly $200–$500 per month at typical compounded doses.
- Tissue-repair / recovery peptides: commonly $200–$600 per month depending on peptide and duration.
- GLP-1 weight-management medication (semaglutide/tirzepatide): widely $250–$600 per month for compounded or cash-pay forms; brand retail without insurance can exceed $1,000/month.
- NAD+ therapy: IV infusions commonly $250–$800 per session; injectable home protocols are typically lower per dose.
Why Reputable Clinics Rarely Post a Fixed Peptide Price
A peptide protocol is built around your labs, medical history, and goals — not a menu. Two patients asking for "the recovery peptide" may need different agents, doses, and durations, with different costs. Clinics that advertise one flat price for everyone are usually selling a product, not designing care.
The honest answer to "what will this cost me" comes after an evaluation. At our clinic, the $88 evaluation is the step where you get a real number tied to a real plan — and an honest answer if peptide therapy is not appropriate for you at all.
Peptides vs. GLP-1 Medications for Weight Loss
GLP-1 weight-management drugs and other peptides are not interchangeable. GLP-1 medications (semaglutide, tirzepatide) are FDA-approved, backed by large randomized-trial evidence for weight loss, and are the first-line pharmacologic option when medically appropriate. [3][4]
Other peptides may play supporting roles — recovery, body composition, or metabolic support — but the evidence base is narrower and many are compounded rather than approved. A physician evaluates which tool, if any, fits your situation. For a deeper comparison, see our peptides vs weight-loss medications guide.
Key Takeaways
- Peptide therapy is legal in Las Vegas when a Nevada-licensed provider prescribes it after a bona fide evaluation and a licensed pharmacy dispenses it.
- FDA status varies sharply: semaglutide, tirzepatide, bremelanotide, and tesamorelin (a specific HIV indication) are approved; BPC-157, CJC-1295, ipamorelin, and sermorelin are compounded and subject to changing FDA rules.
- In 2023 the FDA flagged BPC-157 as raising significant compounding safety questions, which restricts how 503A pharmacies may compound it.
- Nevada permits peptide prescribing via telemedicine once a valid provider-patient relationship is established.
- Typical Las Vegas protocol costs vary by peptide, pharmacy, and protocol length — real cost is set after your evaluation, not from an online menu.
- Avoid "research use only" peptide vendors; those products are not legal medical use and are not tested for human administration.
Common Questions
Is peptide therapy legal in Las Vegas?
Yes. Peptide therapy is legal in Nevada when a licensed physician prescribes it for an individual patient after a bona fide evaluation and a licensed pharmacy dispenses it. It is not legal to buy unprescribed "research chemical" peptides online, and those products are not tested for human administration.
Which peptides are FDA-approved in 2026?
Among commonly requested agents, semaglutide (Wegovy/Ozempic), tirzepatide (Zepbound/Mounjaro), bremelanotide (Vyleesi), and tesamorelin (Egrifta, for a specific HIV indication) are FDA-approved. Many others such as BPC-157, CJC-1295, ipamorelin, and sermorelin are not approved finished drugs and are available only through compounding when permitted.
How much does peptide therapy cost in Las Vegas?
At LiveNow Longevity you start with an $88 physician evaluation that is applied toward your protocol if you continue. Medications are then billed at pass-through cost with no markup, and your individual protocol price is reviewed in person. Typical 2026 market protocols run a few hundred dollars per month.
Is BPC-157 legal in Nevada?
BPC-157 is not FDA-approved, and in 2023 the FDA flagged it as raising significant compounding safety questions, which restricts how pharmacies may compound it. Whether it can be lawfully prescribed and compounded depends on its current FDA status, so a licensed physician will only prescribe what is permitted at the time.
Can I get peptide therapy through telemedicine in Nevada?
Yes. Nevada permits peptide prescribing via telemedicine once a valid provider-patient relationship is established. Many patients complete an initial evaluation and then continue care remotely, with prescriptions dispensed through a licensed pharmacy. Telemedicine does not remove the requirement for a bona fide medical evaluation.
How can I tell a legitimate peptide clinic from a "research use only" storefront?
A legitimate clinic is physician-led and evaluation-based: it requires a bona fide medical evaluation, dispenses through a licensed pharmacy, is honest about each peptide's FDA status and cost, and prescribes only what is lawfully compoundable at the time. A storefront sells "research use only" products with no prescription and no medical oversight.
Peptide therapy in Las Vegas is legal, increasingly common, and highly variable in quality. The clinics worth your trust are physician-led, evaluation-based, and honest about FDA status and cost. Schedule your $88 medical evaluation with Dr. Kamen, or learn more about our Las Vegas peptide clinic and peptide therapy protocols.
References
- Nevada Revised Statutes Chapter 639 (Pharmacists and Pharmacy) and Chapter 453 (controlled substances framework).
- Nevada Revised Statutes 629.515 (telehealth) and Nevada State Board of Medical Examiners telemedicine guidance.
- Wilding JPH, et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity. N Engl J Med. 2021;384(11):989-1002. (STEP 1)
- Jastreboff AM, et al. Tirzepatide Once Weekly for the Treatment of Obesity. N Engl J Med. 2022;387(3):205-216. (SURMOUNT-1); FDA approval of Zepbound, November 2023.
- U.S. FDA. Compounding and the FDA: 503A and 503B; FDA evaluation of bulk drug substances nominated for compounding (2023 determinations affecting certain peptides).
Wondering what’s right for you?
Get a straight answer from board-certified neurologist Dr. Charles Kamen, MD. The evaluation is $88 and is applied toward your protocol if you continue care.